Skip to main content
Figure 4 | BMC Clinical Pharmacology

Figure 4

From: Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell®)

Figure 4

Smoking cessation success rates among users of 1 mg nicotine lozenges (moderately dependent patients) (adopted from [17]). The rate of fully (no cigarettes) or partially (≤ 1 cigarette/day and ≤ 7 cigarettes/week) abstinent subjects using 1 mg nicotine lozenges for abrupt quitting over the first 6 months of the French efficacy trial.

Back to article page

BMC Clinical Pharmacology

ISSN: 1472-6904